Insmed Incorporated (NASDAQ:INSM) Q3 2020 Earnings Conference Call October 29, 2020 8:30 AM ET Company Participants Sara Bonstein - Chief Financial Officer Will Lewis - Chair & Chief Executive Officer Martina Flammer - Chief Medical Officer Roger Adsett - Chief Operating Officer Kevin Mange - Head of Clinical Development Conference Call Participants Ritu Baral - Cowen Martin Auster - Credit Suisse Stephen Willey - Stifel Connor Meehan - Morgan Stanley John McNeil - Goldman Sachs Joseph Schwartz - SVB Leerin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) 700 US Highway 202/206, Bridgewater, New Jersey 08807 (Address of principal executive offices) (Zip Code) For the quarterly period end ...

Insmed Incorporated (NASDAQ:INSM) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Stacey Jurchison - Investor Relations William Lewis - Chair and Chief Executive Officer Sara Bonstein - Chief Financial Officer Martina Flammer - Chief Medical Officer Roger Adsett - Chief Operating Officer Conference Call Participants Martin Auster - Credit Suisse Lyla Youssef - Cowen and Company Joseph Schwartz - SVB Leerink Matthew Harrison - Morgan Stanley Operator Good morning, and welcome ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdiction ...

Insmed Incorporated (NASDAQ:INSM) Q1 2020 Results Conference Call April 30, 2020 8:30 AM ET Company Participants Sara Bonstein - CFO Will Lewis - Chairman and CEO Roger Adsett - COO Dr. Martina Flammer - Chief Medical Officer Conference Call Participants Connor Meehan - Morgan Stanley Adam Walsh - Stifel Martin Auster - Credit Suisse Ritu Baral - Cowen Joe Schwartz - SVB Leerink Liisa Bayko - JMP Graig Suvannavejh - Goldman Sachs Josh Schimmer - Evercore ISI Operator Good day, and welcome to the Insmed Firs ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdictio ...

| --- | --- | --- | --- | --- | |----------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | 2019 Financial Results and Corporate Update February 25, 2020 | | | | | | | | | | | Not for promotional use Forward-Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia (State or other jurisdiction ...

Insmed Incorporated (NASDAQ:INSM) Q3 2019 Earnings Conference Call October 30, 2019 8:30 AM ET Company Participants Blaine Davis - Head of Investor Relations Will Lewis - Chairman and Chief Executive Officer Roger Adsett - Chief Commercial Officer John Goll - Senior Vice President and Chief Accounting Officer Conference Call Participants Liisa Bayko - JMP Securities Ritu Burrell - Cowen Josh Schimmer - Evercore ISI Graig Suvannavejh - Goldman Sachs Matthew Harrison - Morgan Stanley Adam Walsh - Stifel Finan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (Address of principal e ...